Jointechlabs Inc. (JTL) desires to be the worldwide leader in point-of-care regenerative medicine therapies. Our FDA approved device MiniTC, and CE Mark pending Mini-Stem system enable healthcare practitioners and hospitals worldwide to provide safe, reliable, cost-effective non-surgical interventional medicine treatments at the point-of-care without significant change in infrastructure. Our devices are patented, disposable, and closed loop that can isolate cell enriched fat grafts (also called nanofat) and stem cell fraction (SVF) from fat. Our pipeline products are FDA approvable stem cell therapies based on our technology for indications with unmet medical needs.
Shared 2 months ago
1 view
Shared 2 months ago
5 views
Shared 3 months ago
89 views
Shared 11 months ago
17 views
Shared 1 year ago
42 views
Shared 1 year ago
12 views
Shared 1 year ago
41 views
Shared 1 year ago
65 views
Shared 1 year ago
15 views
Shared 1 year ago
26 views
Shared 1 year ago
22 views
Shared 1 year ago
7 views
Shared 1 year ago
11 views
Shared 1 year ago
3 views
Shared 1 year ago
13 views
Shared 1 year ago
15 views
Shared 1 year ago
12 views
Shared 1 year ago
21 views
Shared 1 year ago
6 views
Shared 1 year ago
45 views